All cashed up and ready to launch, years ahead of time.
"“COVID-19 presents a unique opportunity to fast-track adoption of digital health and maternity care, and HeraMED is well-placed to deliver high-quality pre and post-natal care to expectant mothers globally.
“As announced, we have recently achieved several key strategic milestones including securing clinical studies in the US and Australia which are ongoing. Supported by a strengthened balance sheet, HeraMED is now well placed to expand our network of collaborations and partnerships in strategically important locations, to secure further validation and ultimately to drive adoption.
“The growing demand for innovative remote monitoring and maternity telehealth solutions continues with interest from leading healthcare providers globally in relation to both HeraCARE and HeraBEAT Plus."
Going to be a big, company making, second half of 2020...
Just an opinion...
TCG
HMD Price at posting:
10.0¢ Sentiment: Buy Disclosure: Held
